| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 67.571 | 45.326 | 50.553 | 60.008 | 88.952 | 70.696 | 101.705 | 106.933 | 105.297 | 92.059 |
| Total Income - EUR | 73.737 | 47.097 | 51.526 | 75.596 | 89.061 | 86.672 | 102.150 | 108.333 | 109.486 | 93.424 |
| Total Expenses - EUR | 68.794 | 48.284 | 79.402 | 84.021 | 89.171 | 88.042 | 72.219 | 79.455 | 106.123 | 95.430 |
| Gross Profit/Loss - EUR | 4.943 | -1.187 | -27.877 | -8.425 | -110 | -1.370 | 29.931 | 28.877 | 3.363 | -2.006 |
| Net Profit/Loss - EUR | 2.863 | -2.557 | -29.404 | -10.691 | -2.779 | -3.348 | 27.105 | 26.782 | 2.436 | -4.608 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Ionex-Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 19.025 | 13.743 | 27.686 | 48.546 | 33.512 | 25.137 | 13.983 | 8.583 | 28.061 | 29.850 |
| Current Assets | 126.034 | 64.406 | 10.752 | 22.672 | 27.037 | 38.922 | 95.546 | 66.025 | 49.306 | 47.240 |
| Inventories | 0 | 17.175 | 0 | 0 | 0 | 2.720 | 5.086 | 4.393 | 404 | 0 |
| Receivables | 0 | 2.299 | 0 | 347 | 0 | 1.112 | 15.092 | 7.363 | 0 | 0 |
| Cash | 126.034 | 44.932 | 10.752 | 22.325 | 27.037 | 35.089 | 75.369 | 54.268 | 48.902 | 47.240 |
| Shareholders Funds | 144.083 | 140.056 | 108.283 | 95.604 | 90.974 | 85.901 | 111.102 | 74.927 | 77.136 | 72.096 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 10.833 | 12.939 | 4.163 | 30.101 | 5.196 | 630 | 635 | 1.355 | 1.363 | 5.584 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Ionex-Med Srl